Suppr超能文献

利奈唑胺对非传统病原体的抗菌活性。

The antimicrobial activity of linezolid against unconventional pathogens.

作者信息

Wang Ting, Zhang Huiyue, Feng Rui, Ren Jieru, Xu Xinping, Sun Shujuan

机构信息

Shandong Second Provincial General Hospital, Jinan, China.

出版信息

PeerJ. 2025 Feb 12;13:e18825. doi: 10.7717/peerj.18825. eCollection 2025.

Abstract

Linezolid is an oxazolidinone antibiotic that is mainly permitted to treat Gram-positive bacterial infections. Recent studies have shown that linezolid also has antibacterial effects on several other bacteria outside the package insert, including , non-tuberculous mycobacteria (NTM), , , and anaerobes, . Interestingly, linezolid also has an inhibitory effect on fungi. This review focuses on the antibacterial activity of linezolid against microorganisms outside its antibacterial spectrum. We mainly listed the number of the tested strains, the minimum inhibitory concentration (MIC) range, MIC, and MIC of linezolid against those pathogens outside the package insert. The results showed that among these tested pathogens, linezolid displayed strong inhibitory effects against , , and , with an MIC range of ≤2 μg/mL. As for NTM, linezolid exhibited moderate to potent inhibitory effects against the strains of different species with an MIC range of 0.06-128 μg/mL. Moreover, linezolid was reported to have a species-dependent inhibitory effect on anaerobes at a concentration range of 0.003-16 μg/mL. Furthermore, linezolid could enhance azoles and amphotericin B's antifungal activity on synergistically. It is hoped that this analysis can provide data for expanding the application of linezolid, make the off-label drug use have more compelling evidence, and provide clues for the development of new drugs.

摘要

利奈唑胺是一种恶唑烷酮类抗生素,主要被批准用于治疗革兰氏阳性菌感染。最近的研究表明,利奈唑胺对药品说明书之外的其他几种细菌也有抗菌作用,包括非结核分枝杆菌(NTM)、、、和厌氧菌、。有趣的是,利奈唑胺对真菌也有抑制作用。本综述聚焦于利奈唑胺对其抗菌谱外微生物的抗菌活性。我们主要列出了受试菌株的数量、利奈唑胺对药品说明书之外那些病原体的最低抑菌浓度(MIC)范围、MIC以及MIC。结果显示,在这些受试病原体中,利奈唑胺对、和表现出强烈的抑制作用,MIC范围≤2μg/mL。至于NTM,利奈唑胺对不同菌种的菌株表现出中度至强效的抑制作用,MIC范围为0.06 - 128μg/mL。此外,据报道利奈唑胺在0.003 - 16μg/mL的浓度范围内对厌氧菌有菌种依赖性抑制作用。此外,利奈唑胺可协同增强唑类和两性霉素B对的抗真菌活性。希望该分析能为扩大利奈唑胺的应用提供数据,使超说明书用药有更令人信服的证据,并为新药研发提供线索。

相似文献

1
The antimicrobial activity of linezolid against unconventional pathogens.
PeerJ. 2025 Feb 12;13:e18825. doi: 10.7717/peerj.18825. eCollection 2025.
3
Susceptibility Testing of Tedizolid against Isolates of Nocardia.
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01537-17. Print 2017 Dec.
4
Evaluation of the Efficacy of Novel Oxazolidinone Analogues against Nontuberculous Mycobacteria In Vitro.
Jpn J Infect Dis. 2015;68(6):520-2. doi: 10.7883/yoken.JJID.2014.498. Epub 2015 May 12.
5
Susceptibility Testing of Tedizolid against Nontuberculous Mycobacteria.
J Clin Microbiol. 2017 Jun;55(6):1747-1754. doi: 10.1128/JCM.00274-17. Epub 2017 Mar 22.
6
Sudapyridine (WX-081) antibacterial activity against , , and and .
mSphere. 2024 Feb 28;9(2):e0051823. doi: 10.1128/msphere.00518-23. Epub 2024 Jan 19.
9
Activity of the Sudapyridine (WX-081) against Non-Tuberculous Mycobacteria Isolated in Beijing, China.
Microbiol Spectr. 2022 Dec 21;10(6):e0137222. doi: 10.1128/spectrum.01372-22. Epub 2022 Oct 17.

引用本文的文献

本文引用的文献

1
an emerging pathogen that is easily misdiagnosed and given treatment as a fungus.
Front Cell Infect Microbiol. 2024 Aug 29;14:1430032. doi: 10.3389/fcimb.2024.1430032. eCollection 2024.
3
In vitro activity of tedizolid against 43 species of Nocardia species.
Sci Rep. 2024 Mar 4;14(1):5342. doi: 10.1038/s41598-024-55916-7.
4
Bedaquiline, Delamanid, Linezolid, Clofazimine, and Capreomycin MIC Distributions for Drug Resistance in Shanghai, China.
Infect Drug Resist. 2023 Dec 11;16:7587-7595. doi: 10.2147/IDR.S440711. eCollection 2023.
5
Strategies for the Discovery of Oxazolidinone Antibacterial Agents: Development and Future Perspectives.
J Med Chem. 2023 Oct 26;66(20):13860-13873. doi: 10.1021/acs.jmedchem.3c01040. Epub 2023 Oct 9.
6
activities of contezolid (MRX-I) against drug-sensitive and drug-resistant .
Microbiol Spectr. 2023 Sep 21;11(5):e0462722. doi: 10.1128/spectrum.04627-22.
7
Micrococcus spp. as a promising source for drug discovery: A review.
J Ind Microbiol Biotechnol. 2023 Feb 17;50(1). doi: 10.1093/jimb/kuad017.
8
Characterization of Resistance to Linezolid in Mycobacterium abscessus.
Microbiol Spectr. 2023 Aug 17;11(4):e0219923. doi: 10.1128/spectrum.02199-23. Epub 2023 Jul 17.
9
Mechanisms of Linezolid Resistance in Mycobacteria.
Pharmaceuticals (Basel). 2023 May 24;16(6):784. doi: 10.3390/ph16060784.
10
Recent Trends in Antimicrobial Resistance among Anaerobic Clinical Isolates.
Microorganisms. 2023 Jun 1;11(6):1474. doi: 10.3390/microorganisms11061474.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验